Gut Microbiome and Diabetes

The gut microbiome, consisting of trillions of microorganisms in the digestive tract, plays a crucial role in regulating metabolism and has been linked to the development of diabetes. Studies have shown that an imbalance in gut bacteria—referred to as dysbiosis—can contribute to insulin resistance, inflammation, and impaired glucose metabolism, all of which are key factors in Type 2 Diabetes. Researchers are investigating how changes in the gut microbiome may influence the body’s response to insulin and glucose regulation. Probiotics, prebiotics, and dietary interventions aimed at restoring a healthy microbiome are being explored as potential treatments for diabetes. While more research is needed, the gut microbiome presents a promising target for new therapeutic approaches to manage or prevent diabetes.

    Related Conference of Gut Microbiome and Diabetes

    February 09-10, 2026

    20th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    February 12-13, 2026

    5th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    February 25-26, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada

    Gut Microbiome and Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in